Web15 Aug 2024 · The aim of this review is to bring attention to the advances in miniaturised high-performance liquid chromatography (HPLC) systems and the endeavours to bring … Web7 Apr 2024 · In this systematic review and meta-analysis incorporating nine eligible observational studies, we showed that patients with SCLC who had high levels of ctDNA had poor OS and PFS. Subsequently, the validity of the results was further proven by consistent results of sensitivity and subgroup analyses.
SCLC: Epidemiology, Risk Factors, Genetic
Web3 Feb 2024 · Background The NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology (NCCN guidelines) recommend radical resection for T1-2N0M0 patients with limited-stage small cell lung cancer (LS-SCLC). However, only about 5% of patients with small cell cancer (SCLC) were initially diagnosed as T1-2N0M0. The … Web14 Jan 2024 · Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by an exceptionally high proliferative rate, strong predilection for early metastasis … delaware gun legislation
Emerging therapies for small cell lung cancer Journal of …
WebSCLC is an aggressive high-grade neuroendocrine tumor characterized by rapid growth and early development of metastatic spread. Most SCLC patients have metastatic disease at the initial diagnosis, and about one-third of them has limited disease confined to the chest, whereas two-thirds of them has hematogenous metastases. Web16 Aug 2024 · Extensive-stage small-cell lung cancer (SCLC) occurs almost exclusively in heavy smokers and accounts for approximately 15% of all lung cancers. 1 The prognosis is generally poor, with a median overall survival (OS) of 8 to 12 months and a 2-year OS rate of 5%. 2,3 Although response rates of 50% to 80% are achieved in first-line treatment with a … Web6 Sep 2024 · Overall, the challenge with immunotherapy in relapsed SCLC and, in particular, in platinum resistant or refractory relapsed SCLC, is two-fold: (1) that due to the high burden of disease and the rapidity of progression the time that it takes to mount an effective anti-tumor response, typically up to 3–6 months, may exceed the overall survival of the patient … delaware gun shops